Corporate Legal & Strategic Advisory Services

VBC provides sophisticated corporate legal and strategic advisory services to biotechnology, life sciences, medical device, and innovation-driven companies. Our services combine executive-level legal leadership with deep scientific and operational experience to support growth, financing, regulatory progress, and long-term enterprise value.

Chemistry, Manufacturing, and Controls (CMC)

Establish a strategy that meets regulatory requirements from agencies like the FDA and EMA, and other regulatory agencies.

  • CMC: IND-enabling
  • The Pre-BLA Phase
  • NDA/BLA Submission

Process Development and Manufacturing of Drug Substance (DS) and Drug Product (DP) and Automation

Upstream (USP) Support for Drug Substance (DS)
Downstream (DSP) Support for Drug Substance (DS)
Analytical and Assay Development: VBC Provides Technical Design and Analysis
Fill-Finish Support for Drug Product (DP)

Regulatory Support of IND-enabling, BLA and NDA

Regulatory strategy development: Creating a comprehensive plan for how a product will navigate regulatory requirements and identifying the most efficient approval pathway. This begins during early product development to minimize delays.

Submission preparation and management: Handling the extensive documentation required for applications to regulatory agencies.

cGMP Facility Build Out, Retrofit, and cGMP Audit

Designing and building a GMP (Good Manufacturing Practices) facility involves a structured, multi-phase process focused on preventing contamination, ensuring product quality, and meeting strict regulatory standards (FDA, EMA, etc.)

Next Generation Sequencing and Bioinformatics Services

  • Workflow development: Creating customized bioinformatics pipelines for diverse research goals, such as cancer genomics or microbiome studies.
  • Data interpretation: Translating raw sequencing data into meaningful biological insights.
  • Variant analysis: Identifying genetic variants, including single nucleotide polymorphisms (SNPs) and structural variations.
  • Transcriptomics (RNA-Seq): Analyzing gene expression patterns to understand biological regulation

Capital Investment and NewCo

VBC helps investors and companies navigate the complex science, regulatory, and financial aspects of the life sciences sector, offering services like due diligence, market analysis, R&D strategy, valuation, and regulatory guidance, provided by specialized firms or individual experts, to make informed decisions on funding and growth.

VBC provides crucial insights into drug pipelines, clinical data, market potential, and competitive landscapes, crucial for success in a high-risk, high-reward industry.

In-licensing and Out-licensing Services

We support biopharmaceutical companies across the full licensing lifecycle, from asset scouting and strategic evaluation to deal execution and post-transaction support. Our services cover both in-licensing and out-licensing, combining deep scientific insight, commercial strategy, and transaction expertise to maximize asset value.

In addition, we advise on the out-licensing of proprietary platform technologies – including advanced LNP/nanobody display systems, AAV and AVV delivery platforms – helping clients identify the right partners and structure competitive, value-driven agreements with global reach.

Website Builder and Maintenance

VBC provides comprehensive and professional website design, contents, logo, security package, business email, SEO, regular update/maintenance with integrated AI, and generate text and marketing campaigns.

We design and build a wide range of website types – from corporate and biotech-focused platforms to e-commerce, educational, and community-based sites – ensuring each solution is secure, scalable, and aligned with our clients’ business and communication objectives.